期刊
INTERNATIONAL JOURNAL OF PHARMACEUTICS
卷 390, 期 1, 页码 84-88出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.ijpharm.2009.10.010
关键词
Gene therapy; Lung; Viral vectors; Non-viral vectors; Nanocarriers
The success of gene transfer in preclinical animal models and proof of principle clinical studies has made gene therapy an attractive concept for disease treatment. A variety of diseases affecting the lung are candidates for gene therapy. Delivery of genes to the lungs seems to be straightforward, because of the easy accessibility of epithelial cells via the airways. However, efficient delivery and expression of the therapeutic transgene at levels sufficient to result in phenotypic correction of the diseased state have proven elusive. This review presents a brief summary about current status and future prospects in the development of viral and non-viral strategies for pulmonary gene therapy. (C) 2009 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据